GB1275, a first-in-class CD11b modulator: Rationale for immunotherapeutic combinations in solid tumors

David G. Denardo, Anna Galkin, Jakob Dupont, Lei Zhou, Johanna Bendell

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'GB1275, a first-in-class CD11b modulator: Rationale for immunotherapeutic combinations in solid tumors'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science